Sidley advised CanSino Biologics Inc. (HKEX: 6185) as the Hong Kong and U.S. counsel in its HK$1.25 billion (approximately US$160.5 million) global offering and listing of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Michael Patrini
…
This content is for Standard 1 Year members only. LoginJoin Now